Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This injection is best used first thing in the morning while you have an empty stomach
Presented for research literature review only Lemeshko VV (2002)
One or more items could not be added to cart due to certain restrictions
A 2022 dose-response RCT (Yi et al., Geroscience) at 300/600/900 mg/day raised NAD+ dose-dependently with no safety issues at 60 days
While BPC-157 is generally considered safe, it is crucial to prioritize your safety and consult with a healthcare professional before starting any new treatment
US$ 22.50
US$ 24.47
US$ 24.05
US$ 22.32
US$ 29.27
